Imaging of Non— or Very Subtle Contrast-Enhancing Malignant Gliomas with [C]-Methionine Positron Emission Tomography

In patients with World Health Organization (WHO) grade III glioma with a lack of or minimal (< 1 cm 3 ) magnetic resonance imaging (MRI) contrast enhancement, the volume of the metabolically active part of the tumor was assessed by [ 11 C]-methionine positron emission tomography (MET-PET). Eleven...

Full description

Bibliographic Details
Main Authors: Norbert Galldiks, Lutz W. Kracht, Veronika Dunkl, Roland T. Ullrich, Stefan Vollmar, Andreas H. Jacobs, Gereon R. Fink, Michael Schroeter
Format: Article
Language:English
Published: Hindawi - SAGE Publishing 2011-11-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2011.00014